Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy

被引:85
|
作者
Sun, Hong [1 ,2 ]
Kim, Dhohyung [1 ]
Li, Xiaodong [1 ]
Kiselinova, Maja [1 ,3 ,4 ]
Ouyang, Zhengyu [1 ]
Vandekerckhove, Linos
Shang, Hong [2 ]
Rosenberg, Eric S. [5 ]
Yu, Xu G. [1 ]
Lichterfeld, Mathias [1 ,5 ,6 ]
机构
[1] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[2] China Med Univ, Affiliated Hosp 1, Key Lab AIDS Immunol, Natl Hlth & Family Planning Commiss, Shenyang, Peoples R China
[3] Univ Ghent, HIV Translat Res Unit, B-9000 Ghent, Belgium
[4] Univ Hosp, Ghent, Belgium
[5] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSCRIPTION FACTOR GATA-3; TH17; CELLS; GENE-EXPRESSION; RESERVOIR; INFECTION; LATENT; DIFFERENTIATION; IDENTIFICATION;
D O I
10.1128/JVI.01595-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability to persist long term in latently infected CD4 T cells represents a characteristic feature of HIV-1 infection and the predominant barrier to efforts aiming at viral eradication and cure. Yet, increasing evidence suggests that only small subsets of CD4 T cells with specific developmental and maturational profiles are able to effectively support HIV-1 long-term persistence. Here, we analyzed how the functional polarization of CD4 T cells shapes and structures the reservoirs of HIV-1-infected cells. We found that CD4 T cells enriched for a Th1/17 polarization had elevated susceptibilities to HIV-1 infection in ex vivo assays, harbored high levels of HIV-1 DNA in persons treated with antiretroviral therapy, and made a disproportionately increased contribution to the viral reservoir relative to their contribution to the CD4 T memory cell pool. Moreover, HIV-1 DNA levels in Th1/17 cells remained stable over many years of antiretroviral therapy, resulting in a progressively increasing contribution of these cells to the viral reservoir, and phylogenetic studies suggested preferential long-term persistence of identical viral sequences during prolonged antiretroviral treatment in this cell compartment. Together, these data suggest that Th1/17 CD4 T cells represent a preferred site for HIV-1 DNA long-term persistence in patients receiving antiretroviral therapy. IMPORTANCE Current antiretroviral therapy is very effective in suppressing active HIV-1 replication but does not fully eliminate virally infected cells. The ability of HIV-1 to persist long term despite suppressive antiretroviral combination therapy represents a perplexing aspect of HIV-1 disease pathogenesis, since most HIV-1 target cells are activated, short-lived CD4 T cells. This study suggests that CD4 T helper cells with Th1/17 polarization have a preferential role as a long-term reservoir for HIV-1 infection during antiretroviral therapy, possibly because these cells may imitate some of the functional properties traditionally attributed to stem cells, such as the ability to persist for extremely long periods of time and to repopulate their own pool size through homeostatic self-renewal. These observations support the hypothesis that HIV-1 persistence is driven by small subsets of long-lasting stem cell-like CD4 T cells that may represent particularly promising targets for clinical strategies aiming at HIV-1 eradication and cure.
引用
收藏
页码:11284 / 11293
页数:10
相关论文
共 50 条
  • [31] Persistence of VRC01-resistant HIV-1 during antiretroviral therapy
    Guo DongXing
    Shi XuanLing
    Song DingKa
    Zhang LinQi
    SCIENCE CHINA-LIFE SCIENCES, 2014, 57 (01) : 88 - 96
  • [32] Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence
    Pomerantz, RJ
    AIDS, 2001, 15 (10) : 1201 - 1211
  • [33] Persistence of VRC01-resistant HIV-1 during antiretroviral therapy
    GUO DongXing
    SHI XuanLing
    SONG DingKa
    ZHANG LinQi
    Science China(Life Sciences), 2014, (01) : 88 - 96
  • [34] Persistence of VRC01-resistant HIV-1 during antiretroviral therapy
    GUO DongXing
    SHI XuanLing
    SONG DingKa
    ZHANG LinQi
    Science China(Life Sciences), 2014, 57 (01) : 88 - 96
  • [35] Progressive reduction of CMV-specific CD4+ T cells in HIV-1 infected individuals during antiretroviral therapy
    Grosse, V
    Schulte, A
    Weber, K
    Mendila, M
    Jacobs, R
    Schmidt, RE
    Heiken, H
    IMMUNOBIOLOGY, 2000, 202 (02) : 179 - 185
  • [36] SOLUBLE CD4 DURING HUMAN HIV-1 INFECTION
    DEPAOLI, P
    BASAGLIA, G
    GENNARI, D
    JUS, A
    CROVATTO, M
    SANTINI, G
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1991, 4 (01) : 61 - 65
  • [37] CD2 facilitates differentiation of CD4 Th cells without affecting Th1/Th2 polarization
    Sasada, T
    Yang, HL
    Reinherz, EL
    JOURNAL OF IMMUNOLOGY, 2002, 168 (03): : 1113 - 1122
  • [38] HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells
    Rinaldo, Charles R.
    SCIENTIFICA, 2013, 2013
  • [39] Enhanced CD4+T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
    Le, Tuan
    Wright, Edwina J.
    Smith, Davey M.
    He, Weijing
    Catano, Gabriel
    Okulicz, Jason F.
    Young, Jason A.
    Clark, Robert A.
    Richman, Douglas D.
    Little, Susan J.
    Ahuja, Sunil K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03): : 218 - 230
  • [40] CHANGES IN CYTOKINE RELEASE BY CD4(+) T-CELLS IN HIV-1 INFECTION
    MEYAARD, L
    MIEDEMA, F
    RESEARCH IN IMMUNOLOGY, 1994, 145 (8-9): : 607 - 611